Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieron Dunleavy

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H Wilson
Blood|February 17, 2012
How I treat HIV-associated lymphomaKieron Dunleavy, Wyndham H Wilson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2011
Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H Wilson
Cancers|October 29, 2025
Novel Molecular Insights and Evolution of Less Toxic Therapeutic Strategies in Burkitt LymphomaCoen J Lap, Kieron Dunleavy
Blood|February 12, 2011
Sobering realities of surviving Hodgkin lymphomaKieron Dunleavy, Catherine M Bollard
Blood|July 23, 2013
Scouting out the neighborhood in AIDS-related lymphomaKieron Dunleavy, Catherine M Bollard
Journal of the National Cancer Institute|July 30, 2013
Implications of the shifting pathobiology of AIDS-related lymphomaKieron Dunleavy, Wyndham H Wilson
Blood|June 14, 2018
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspectiveKieron Dunleavy, Thomas G Gross
Leukemia & Lymphoma|October 27, 2006
Primary intraocular lymphoma: current and future perspectivesKieron Dunleavy, Wyndham H Wilson
Blood Advances|September 10, 2021
Optimizing outcomes in primary mediastinal B-cell lymphoma: is R-CHOP enough?Michael R Cook, Kieron Dunleavy
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H Wilson
Blood|February 17, 2012
How I treat HIV-associated lymphomaKieron Dunleavy, Wyndham H Wilson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2011
Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Wyndham H Wilson
Cancers|October 29, 2025
Novel Molecular Insights and Evolution of Less Toxic Therapeutic Strategies in Burkitt LymphomaCoen J Lap, Kieron Dunleavy
Blood|February 12, 2011
Sobering realities of surviving Hodgkin lymphomaKieron Dunleavy, Catherine M Bollard
Blood|July 23, 2013
Scouting out the neighborhood in AIDS-related lymphomaKieron Dunleavy, Catherine M Bollard
Journal of the National Cancer Institute|July 30, 2013
Implications of the shifting pathobiology of AIDS-related lymphomaKieron Dunleavy, Wyndham H Wilson
Blood|June 14, 2018
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspectiveKieron Dunleavy, Thomas G Gross
Leukemia & Lymphoma|October 27, 2006
Primary intraocular lymphoma: current and future perspectivesKieron Dunleavy, Wyndham H Wilson
Blood Advances|September 10, 2021
Optimizing outcomes in primary mediastinal B-cell lymphoma: is R-CHOP enough?Michael R Cook, Kieron Dunleavy
Pageof 13